Horizons in Cancer Research Volume 65

Horizons in Cancer Research
  • Engels
  • Hardcover
  • 9781536109443
  • mei 2017
  • 180 pagina's
Alle productspecificaties

Samenvatting

This book presents original results on the leading edge of cancer research. Chapter One provides a comprehensive discussion to address the potential benefits of myricetin on cancer, diabetes, and neurodegenerative disease. It also discusses the underlined mechanism involved in the biological action of myricetin. Chapter Two discusses the clinical significance of vasculogenic mimicry. Chapter Three studies bacterial toxins as a direct cause of cancer. Chapter Four examines the immunological aspect of stroma in ovarian cancer. Chapter Five focuses on immune checkpoint inhibitors in the treatment of solid tumors. Chapter Six provides a review of targeting non-coding mitochondrial RNAs in gynecological and urinary malignancies. Chapter Seven explores the NF- B signaling pathway, and its targeting in human cancer treatment. Chapter Eight analyses the circadian rhythm and skin cancer prevention. The final section of this book is a short commentary on melanoma.

Productspecificaties

Inhoud

Taal
Engels
Bindwijze
Hardcover
Verschijningsdatum
mei 2017
Aantal pagina's
180 pagina's
Illustraties
Nee

Betrokkenen

Redacteur
Watanabe, Hiroto S
Uitgever
Nova Science Publishers Inc

EAN

EAN
9781536109443

Overige kenmerken

Gewicht
446 g
Verpakking breedte
155 mm
Verpakking hoogte
230 mm
Verpakking lengte
230 mm

Je vindt dit artikel in

Categorieën
Taal
Engels
Snelle bezorgopties
Gratis verzending
Boek, ebook of luisterboek?
Boek
Nog geen reviews
Bindwijze: Hardcover
247 50
1 - 2 weken Tooltip
In winkelwagen
Wat je kan verwachten:
  • Bestellen en betalen via bol.com
  • Prijs inclusief verzendkosten, verstuurd door Books2Anywhere
  • 30 dagen bedenktijd en gratis retourneren
  • Wettelijke garantie via Books2Anywhere